Skip to main content
SpringerLink
Log in

Prognostic Markers and the LAS for Lung Transplantation: Impact of New Revisions for Successful Outcome

  • Chapter
  • First Online:
Lung Transplantation

Abstract

This chapter reviews the history, development, and institution of the lung allocation score (LAS) in the United States. Lung transplantation can be a lifesaving therapy for patients suffering with end-stage lung diseases for which there are no remaining therapeutic options available. Unfortunately, there remains an imbalance between the number of patients in need of this therapy and the availability of suitable donor organs for transplantation. The LAS was developed in the spirit of the important ethical principles in transplantation of utility and justice. More specifically, the objective of the LAS is to decrease waitlist time (and thus risk for waitlist mortality) and to allocate organs based upon medical urgency so as to balance predicted urgency with predicted benefit. The institution of the LAS for the allocation of suitable donor lungs to appropriate candidates on May 4, 2005, literally changed the landscape of lung transplantation overnight. This chapter also explores the ongoing evolution of the LAS as advancements continue to be made in medical therapies and technologies available for the support and management of end-stage lung diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Cooper JD, Pearson FG, Patterson GA, et al. Technique of successful lung transplantation in humans. J Thorac Cardiovasc Surg. 1987;93(2):173–81.

    PubMed  CAS  Google Scholar 

  2. Egan TM, Murray S, Bustami RT, et al. Development of the new lung allocation system in the United States. Am J Transplant. 2006;6(5 Pt 2):1212–27.

    Article  CAS  PubMed  Google Scholar 

  3. Health Resources and Services Administration, HHS. Organ procurement and transplantation network. Final rule. Fed Regist. 2007;72(46):10616–9.

    Google Scholar 

  4. McCurry KR, Shearon TH, Edwards LB, et al. Lung transplantation in the United States, 1998-2007. Am J Transplant. 2009;9(4 Pt 2):942–58.

    Article  CAS  PubMed  Google Scholar 

  5. Gries CJ, Mulligan MS, Edelman JD, Raghu G, Curtis JR, Goss CH. Lung allocation score for lung transplantation: impact on disease severity and survival. Chest. 2007;132(6):1954–61.

    Article  PubMed  Google Scholar 

  6. Osaki S, Maloney JD, Meyer KC, Cornwell RD, Edwards NM, De Oliveira NC. The impact of the lung allocation scoring system at the single national Veterans Affairs Hospital lung transplantation program. Eur J Cardiothorac Surg. 2009;36(3):497–501.

    Article  PubMed  Google Scholar 

  7. Kozower BD, Meyers BF, Smith MA, et al. The impact of the lung allocation score on short-term transplantation outcomes: a multicenter study. J Thorac Cardiovasc Surg. 2008;135(1):166–71.

    Article  PubMed  Google Scholar 

  8. Wille KM, Harrington KF, deAndrade JA, Vishin S, Oster RA, Kaslow RA. Disparities in lung transplantation before and after introduction of the lung allocation score. J Heart Lung Transplant. 2013;32(7):684–92.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Egan TM, Edwards LB. Effect of the lung allocation score on lung transplantation in the United States. J Heart Lung Transplant. 2016;35(4):433–9.

    Article  PubMed  Google Scholar 

  10. Osho AA, Castleberry AW, Snyder LD, et al. Differential outcomes with early and late repeat transplantation in the era of the lung allocation score. Ann Thorac Surg. 2014;98(6):1914–20, discussion1920–1.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Iribarne A, Russo MJ, Davies RR, et al. Despite decreased wait-list times for lung transplantation, lung allocation scores continue to increase. Chest. 2009;135(4):923–8.

    Article  PubMed  Google Scholar 

  12. Liu V, Zamora MR, Dhillon GS, Weill D. Increasing lung allocation scores predict worsened survival among lung transplant recipients. Am J Transplant. 2010;10(4):915–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Merlo CA, Weiss ES, Orens JB, et al. Impact of U.S. Lung Allocation Score on survival after lung transplantation. J Heart Lung Transplant. 2009;28(8):769–75.

    Article  PubMed  Google Scholar 

  14. Weiss ES, Allen JG, Merlo CA, Conte JV, Shah AS. Lung allocation score predicts survival in lung transplantation patients with pulmonary fibrosis. Ann Thorac Surg. 2009;88(6):1757–64.

    Article  PubMed  Google Scholar 

  15. Russo MJ, Iribarne A, Hong KN, et al. High lung allocation score is associated with increased morbidity and mortality following transplantation. Chest. 2010;137(3):651–7.

    Article  PubMed  Google Scholar 

  16. Russo MJ, Worku B, Iribarne A, et al. Does lung allocation score maximize survival benefit from lung transplantation? J Thorac Cardiovasc Surg. 2011;141(5):1270–7.

    Article  PubMed  Google Scholar 

  17. Maxwell BG, Levitt JE, Goldstein BA, et al. Impact of the lung allocation score on survival beyond 1 year. Am J Transplant. 2014;14(10):2288–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Hayanga JWA, Lira A, Aboagye JK, Hayanga HK, D’Cunha J. Extracorporeal membrane oxygenation as a bridge to lung transplantation: what lessons might we learn from volume and expertise? Interact Cardiovasc Thorac Surg. 2016;22(4):406–10.

    Article  PubMed  Google Scholar 

  19. Horai T, Shigemura N, Gries C, et al. Lung transplantation for patients with high lung allocation score: single-center experience. Ann Thorac Surg. 2012;93(5):1592–7–discussion1597.

    Article  PubMed  Google Scholar 

  20. Shafii AE, Mason DP, Brown CR, et al. Too high for transplantation? Single-center analysis of the lung allocation score. Ann Thorac Surg. 2014;98(5):1730–6.

    Article  PubMed  Google Scholar 

  21. Arnaoutakis GJ, Allen JG, Merlo CA, et al. Impact of the lung allocation score on resource utilization after lung transplantation in the United States. J Heart Lung Transplant. 2011;30(1):14–21.

    Article  PubMed  Google Scholar 

  22. Maxwell BG, Mooney JJ, Lee P. Increased resource use in lung transplant admissions in the lung allocation score era. Am J Respir Crit Care Med. 2015 Feb 1;191(3):302–8.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Tsuang WM, Vock DM, Copeland C. An acute change in lung allocation score and survival after lung transplantation: a cohort study. Ann Intern Med. 2013;158(9):650–7.

    Article  PubMed  Google Scholar 

  24. Schaffer JM, Singh SK, Joyce DL, Reitz BA. Transplantation for idiopathic pulmonary arterial hypertension: improvement in the lung allocation score era. Circulation. 2013;127(25):2503–13.

    Article  PubMed  Google Scholar 

  25. Chen H, Shiboski SC, Golden JA, et al. Impact of the lung allocation score on lung transplantation for pulmonary arterial hypertension. Am J Respir Crit Care Med. 2009;180(5):468–74.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Chan KM. Idiopathic pulmonary arterial hypertension and equity of donor lung allocation in the era of the lung allocation score: are we there yet? Am J Respir Crit Care Med. 2009;180(5):385–7.

    Article  PubMed  Google Scholar 

  27. Benza RL, Miller DP, Frost A, Barst RJ, Krichman AM, Mcgoon MD. Analysis of the lung allocation score estimation of risk of death in patients with pulmonary arterial hypertension using data from the REVEAL Registry. Transplantation. 2010;90(3):298–305.

    Article  PubMed  Google Scholar 

  28. Gomberg-Maitland M, Glassner-Kolmin C, Watson S, et al. Survival in pulmonary arterial hypertension patients awaiting lung transplantation. J Heart Lung Transplant. 2013;32(12):1179–86.

    Article  PubMed  Google Scholar 

  29. Allen LA, Felker GM, Pocock S, et al. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Eur J Heart Fail. 2009;11(2):170–7.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Takeda Y, Takeda Y, Tomimoto S, Tani T, Narita H, Kimura G. Bilirubin as a prognostic marker in patients with pulmonary arterial hypertension. BMC Pulm Med. 2010;10:22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Russo MJ, Davies RR, Hong KN, et al. Who is the high-risk recipient? Predicting mortality after lung transplantation using pretransplant risk factors. J Thorac Cardiovasc Surg. 2009;138(5):1234–1238.e1.

    Article  PubMed  Google Scholar 

  32. Committee OUT. Thoracic Organ Transplatation Committee Meeting Summary [Internet]. 2016;1–3. Available from: http://optn.transplant.hrsa.gov.

  33. Andersen KH, Schultz HHL, Nyholm B, Iversen MP, Gustafsson F, Carlsen J. Pulmonary hypertension as a risk factor for survival after lung transplantation. Clin Transplant. 2016;30(4):357–64.

    Article  PubMed  Google Scholar 

  34. Singh VK, Patricia George M, Gries CJ. Pulmonary hypertension is associated with increased post-lung transplant mortality risk in patients with chronic obstructive pulmonary disease. J Heart Lung Transplant. 2015;34(3):424–9.

    Article  PubMed  Google Scholar 

  35. Hayes D, Higgins RS, Black SM, et al. Effect of pulmonary hypertension on survival in patients with idiopathic pulmonary fibrosis after lung transplantation: an analysis of the United Network of Organ Sharing registry. J Heart Lung Transplant. 2015;34(3):430–7.

    Article  PubMed  Google Scholar 

  36. Hayes D, Higgins RS, Kirkby S, et al. Impact of pulmonary hypertension on survival in patients with cystic fibrosis undergoing lung transplantation: an analysis of the UNOS registry. J Cyst Fibros. 2014;13(4):416–23.

    Article  PubMed  Google Scholar 

  37. Singer JP, Blanc PD, Hoopes C, et al. The impact of pretransplant mechanical ventilation on short- and long-term survival after lung transplantation. Am J Transplant. 2011;11(10):2197–204.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Mason DP, Thuita L, Nowicki ER, Murthy SC, Pettersson GB, Blackstone EH. Should lung transplantation be performed for patients on mechanical respiratory support? The US experience. J Thorac Cardiovasc Surg. 2010;139(3):765–773.e1.

    Article  PubMed  Google Scholar 

  39. Gottlieb J, Warnecke G, Hadem J, et al. Outcome of critically ill lung transplant candidates on invasive respiratory support. Intensive Care Med. 2012;38(6):968–75.

    Article  PubMed  Google Scholar 

  40. Lang G, Taghavi S, Aigner C, et al. Primary lung transplantation after bridge with extracorporeal membrane oxygenation: a plea for a shift in our paradigms for indications. Transplantation. 2012;93(7):729–36.

    Article  PubMed  Google Scholar 

  41. Toyoda Y, Bhama JK, Shigemura N, et al. Efficacy of extracorporeal membrane oxygenation as a bridge to lung transplantation. J Thorac Cardiovasc Surg. 2013;145(4):1065–70, discussion1070–1.

    Article  PubMed  Google Scholar 

  42. Hoopes CW, Kukreja J, Golden J, Davenport DL, Diaz-Guzman E, Zwischenberger JB. Extracorporeal membrane oxygenation as a bridge to pulmonary transplantation. J Thorac Cardiovasc Surg. 2013;145(3):862–7, discussion 867–8.

    Article  PubMed  Google Scholar 

  43. Hayanga AJ, Aboagye J, Esper S, et al. Extracorporeal membrane oxygenation as a bridge to lung transplantation in the United States: an evolving strategy in the management of rapidly advancing pulmonary disease. J Thorac Cardiovasc Surg. 2015;149(1):291–6.

    Article  PubMed  Google Scholar 

  44. Hayes D, Tobias JD, Tumin D. Center volume and extracorporeal membrane oxygenation support at lung transplantation in the Lung Allocation Score Era. Am J Respir Crit Care Med. 2016;194(3):317–26.

    Article  CAS  PubMed  Google Scholar 

  45. Valapour M, Skeans MA, Smith JM, et al. OPTN/SRTR annual data report 2014: lung. Am J Transplant. 2016;16:141–68.

    Article  PubMed  Google Scholar 

  46. Kilic A, Merlo CA, Conte JV, Shah AS. Lung transplantation in patients 70 years old or older: have outcomes changed after implementation of the lung allocation score? J Thorac Cardiovasc Surg. 2012;144(5):1133–8.

    Article  PubMed  Google Scholar 

  47. Singer JP, Peterson ER, Snyder ME, et al. Body composition and mortality after adult lung transplantation in the United States. Am J Respir Crit Care Med. 2014;190(9):1012–21.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Baldwin MR, Arcasoy SM, Shah A, et al. Hypoalbuminemia and early mortality after lung transplantation: a cohort study. Am J Transplant. 2012;12(5):1256–67.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Lederer DJ, Kawut SM, Wickersham N, et al. Obesity and primary graft dysfunction after lung transplantation: the Lung Transplant Outcomes Group Obesity Study. Am J Respir Crit Care Med. 2011;184(9):1055–61.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Chandrashekaran S, Keller CA, Kremers WK, Peters SG, Hathcock MA, Kennedy CC. Weight loss prior to lung transplantation is associated with improved survival. J Heart Lung Transplant. 2015;34(5):651–7.

    Article  PubMed  Google Scholar 

  51. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146–56.

    Article  CAS  PubMed  Google Scholar 

  52. Singer JP, Diamond JM, Gries CJ, et al. Frailty phenotypes, disability, and outcomes in adult candidates for lung transplantation. Am J Respir Crit Care Med. 2015;192(11):1325–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Wilson ME, Vakil AP, Kandel P, Undavalli C. Pretransplant frailty is associated with decreased survival after lung transplantation. J Heart Lung Transplant. 2015;35(2):173–8.

    Article  PubMed  Google Scholar 

  54. Kelm DJ, Bonnes SL, Jensen MD. Pretransplant wasting (as measured by muscle index) is a novel prognostic indicator in lung transplantation. Clin Transplant. 2016 Mar;30(3):247–55.

    Article  PubMed  Google Scholar 

  55. Grimm JC, Valero V, Kilic A, et al. Preoperative performance status impacts perioperative morbidity and mortality after lung transplantation. Ann Thorac Surg. 2015;99(2):482–9.

    Article  PubMed  Google Scholar 

  56. Kilic A, Beaty CA, Merlo CA, Conte JV, Shah AS. Functional status is highly predictive of outcomes after redo lung transplantation: an analysis of 390 cases in the modern era. Ann Thorac Surg. 2013;96(5):1804–11, discussion1811.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, National Jewish Health, Denver, CO, USA

    M. Patricia George

  2. Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

    Matthew R. Pipeling

Authors
  1. M. Patricia George
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Matthew R. Pipeling
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Patricia George .

Editor information

Editors and Affiliations

  1. Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine University of Washington, Seattle, Washington, USA

    Ganesh Raghu

  2. Department of Internal Medicine, University of Genoa, Genoa, Italy

    Roberto G. Carbone

Rights and permissions

Reprints and permissions

Copyright information

© 2018 The Author(s)

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Patricia George, M., Pipeling, M.R. (2018). Prognostic Markers and the LAS for Lung Transplantation: Impact of New Revisions for Successful Outcome. In: Raghu, G., Carbone, R. (eds) Lung Transplantation. Springer, Cham. https://doi.org/10.1007/978-3-319-91184-7_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-91184-7_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-91182-3

  • Online ISBN: 978-3-319-91184-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation